Topics

Novocure’s Optune secures Innovative Medical Device Designation from China NMPA

19:57 EDT 13 Aug 2019 | Compelo Medical Devices

Novocure, along with its Chinese partner Zai Lab, a commercial stage biopharmaceutical company, announced that the China National Medical Products Administration (NMPA) has granted Innovative Medical Device Designation

The post Novocure’s Optune secures Innovative Medical Device Designation from China NMPA appeared first on NS Medical Devices.

Original Article: Novocure’s Optune secures Innovative Medical Device Designation from China NMPA

NEXT ARTICLE

More From BioPortfolio on "Novocure’s Optune secures Innovative Medical Device Designation from China NMPA"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...